About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Team (3)
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
3,923
By Phase
PHASE2: 9PHASE1/PHASE2: 1
By Status
COMPLETED: 5TERMINATED: 5ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT04875351Lead Sponsor
Breast Cancer Index (BCI) Registry
N/AActive, not recruiting
3,465 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2028
NCT04722354Collaborator
Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity
PHASE2Active, not recruiting
48 participants
Started: Mar 8, 2021 · Completed: Dec 31, 2025
NCT01484145Lead Sponsor
Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
PHASE2Completed
25 participants
Started: Dec 31, 2011 · Completed: Apr 30, 2012
NCT01080079Lead Sponsor
Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis
PHASE2Completed
168 participants
Started: May 31, 2010 · Completed: Jun 30, 2012
NCT00893880Lead Sponsor
A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis
PHASE2Completed
92 participants
Started: Jun 30, 2009 · Completed: May 31, 2010
Locations (1)
Headquarters
Blacksburg, VA, United States
Map
Loading map...